Discover how researchers are using Affymetrix products and services to power their experiments in the Featured Researchers. This community features scientists who will share their work with you through hands-on activities and conversation. Learn how scientists detect cancer-causing genes and more.
Bruno Stuhlmüller, PhD, discusses how he is successfully finding mRNA and miRNA biomarkers from whole blood to help predict the best therapy option for rheumatoid arthritis patients.
Dr. Peter Ambros from the Children's Cancer Research Institute (CCRI) in Vienna, Austria discusses the way in which arrays are helping to unravel the complexities of the cancer genome and guiding patient-tailored treatment strategies.
Austin Tanney, PhD, Scientific Liaison Manager for Almac Diagnostics, UK, discusses the opportunities and challenges of working with FFPE tissue, and his visions for technologies driving towards personalized medicine.
Procter & Gamble Company's Jay Tiesman, PhD, discusses the role of genomics in the cosmetics industry.
The University of Utah's Joshua Schiffman, MD, discusses the use of molecular inversion probe (MIP) technology for studying copy number alterations in pediatric cancers.
Boston University's Avrum Spira, MD, discusses the discovery of a gene expression signature and a potential preventative treatment for lung cancer.
The University of Miami's Lisa Baumbach and Maastricht University's Torik Ayoubi discuss how ethnicity-specific genetic changes govern aggressive breast cancer risks.
Chris Smith of Cambridge University, Tyson Clark of Affymetrix and Melissa Cline of UCSC discuss EURASNET's approach for comparing commercial microarrays.
Rob Norgren of The University of Nebraska Medical Center and Katja Nowick of Lawrence Livermore National Laboratory discuss the development of the Rhesus Macaque Genome Array.
Yong-Jie Lu of Queen Mary, University of London and Colleen Elso of the Walter and Eliza Hall Institute discuss a method for rapidly identifying chromosome rearrangements.
Warning! The earliest signals for cancer - miRNA regulation
Featured Social Network
Covering personalized medicine, cancer research, pharmacogenomics, and more